Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Fraser

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 21, 2002
Steps towards improving the security of chaotic encryptionBlair Fraser, Pei Yu, Turab Lookman
The Journal of Chemical Physics|March 18, 2006
On the orientation of lamellar block copolymer phases under shearBlair Fraser, Colin Denniston, Martin H Müser
Nature Reviews. Drug Discovery|July 20, 2007
The FDA's assessment of follow-on protein products: a historical perspectiveJanet Woodcock, Joseph Griffin, Rachel Behrman, et al.
Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.
The New England Journal of Medicine|April 25, 2008
Contaminated heparin associated with adverse clinical events and activation of the contact systemTakashi Kei Kishimoto, Karthik Viswanathan, Tanmoy Ganguly, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 21, 2002
Steps towards improving the security of chaotic encryptionBlair Fraser, Pei Yu, Turab Lookman
The Journal of Chemical Physics|March 18, 2006
On the orientation of lamellar block copolymer phases under shearBlair Fraser, Colin Denniston, Martin H Müser
Nature Reviews. Drug Discovery|July 20, 2007
The FDA's assessment of follow-on protein products: a historical perspectiveJanet Woodcock, Joseph Griffin, Rachel Behrman, et al.
Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.
The New England Journal of Medicine|April 25, 2008
Contaminated heparin associated with adverse clinical events and activation of the contact systemTakashi Kei Kishimoto, Karthik Viswanathan, Tanmoy Ganguly, et al.
Pageof 1